Showing results (81-90 of 108) with videos related to

Sort By:
Pageof 11
Blood|July 25, 2012
SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromesValeria Visconte, Heesun J Rogers, Jarnail Singh, et al.
Blood|June 2, 2021
Machine learning integrates genomic signatures for subclassification beyond primary and secondary acute myeloid leukemiaHassan Awada, Arda Durmaz, Carmelo Gurnari, et al.
Cancer|December 1, 2020
Sequencing of novel agents in relapsed/refractory B-cell acute lymphoblastic leukemia: Blinatumomab and inotuzumab ozogamicin may have comparable efficacy as first or second novel agent therapy in relapsed/refractory acute lymphoblastic leukemiaTalha Badar, Aniko Szabo, Shira Dinner, et al.
Cancer|July 15, 2026
Longitudinal analysis of tyrosine kinase inhibitor therapy outcomes and BCR-ABL1 transcript decline velocity in chronic myeloid leukemia: A 16-year real-world studyMoaath K Mustafa Ali, Emily C Zabor, Kamilla Abdurakhmanov, et al.
American Journal of Hematology|July 11, 2025
Impact of Cytogenetic Response to Therapy on Long-Term Survival in Acute Myeloid LeukemiaJohn Hanna, Emily C Zabor, Moath Albliwi, et al.
Blood Advances|January 26, 2021
Comparison of CALGB 10403 (Alliance) and COG AALL0232 toxicity results in young adults with acute lymphoblastic leukemiaAnjali S Advani, Eric Larsen, Kristina Laumann, et al.
Blood Advances|December 24, 2019
Therapy-related acute lymphoblastic leukemia is a distinct entity with adverse genetic features and clinical outcomesCaner Saygin, Ashwin Kishtagari, Ryan D Cassaday, et al.
Cancer|May 23, 2026
Cytokine receptor and JAK/STAT pathway mutations in acute myeloid leukemia: Prevalence and clinical impactMoath Albliwi, Daniel P Nurse, Emily C Zabor, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 14, 2025
Comparative Outcomes of Intensive Chemotherapy Versus Venetoclax Plus Hypomethylating Agents in Acute Myeloid Leukemia Patients Aged 60-75 Years: A Propensity Score-Adjusted Cohort StudyMoath Albliwi, Emily C Zabor, John Hanna, et al.
Transplantation and Cellular Therapy|August 11, 2021
Influence of Killer Immunoglobulin-Like Receptors and Somatic Mutations on Transplant Outcomes in Acute Myeloid LeukemiaSanghee Hong, Lisa Rybicki, Aiwen Zhang, et al.
Pageof 11